The Michelakis team reports that DCA turns on the mitochondria of cancer cells, allowing them to commit cellular suicide, or apoptosis.
Cancer cells shut down the mitochondria, which is the part of the cell that is involved in metabolism and, incidentally, initiates the cell suicide.
A non-cancerous cell will initiate apoptosis when it detects damage within itself that it cannot repair. But a cancer cell resists the suicide process. That is why chemotherapy and radiation treatments do not work very well and actually result in terrible side effect: the healthy cells actually die much easier.
Michelakis and his team discovered that they could re-activate the mitochondria of cancer cells. Not only that, the DCA is very effective in doing it: To quote from the Michelakis paper: "The decrease in [Ca2+]i occurs within 5 min and is sustained after 48 hr of DCA exposure. The mitochondria are so sensitive to DCA that just 5 minutes of exposure reactivates them for 48 hours.
The metabolic approach to cancer is supported by other research. Inhibition of Glycolysis in Cancer Cells: A Novel Strategy to Overcome Drug Resistance Associated with Mitochondrial Respiratory Defect and Hypoxia is a paper by a John Hopkins research team supporting this approach.
http://www.thedcasite.com/dcaforum/DCForumID1/79.htmll is a post by Willis. giving a prediction as to which cancers DCA might not control, and it is being supported by the reports we are receiving.
We have DCA available at 50 Euros for 50 grams. Dosage is 11 mg per 1kg of body weight, (ie about 1 gram a day for a 100 kg person) and it should be mixed with a glass of water and taken by mouth daily. Taking it with black breakfast tea -caffinated (NOT decaf) and vitamin B1 vastly increases its efffectiveness. But it only works on 55% of people. We don't know why.
If you have any questions call David Noakes on 0044 752 844 1672.
We also have GcMAF available at http://gcmaf.eu